Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1970 2
1971 1
1972 1
1973 3
1974 6
1975 23
1976 44
1977 66
1978 54
1979 82
1980 113
1981 128
1982 134
1983 152
1984 197
1985 216
1986 226
1987 221
1988 293
1989 340
1990 411
1991 434
1992 538
1993 630
1994 636
1995 692
1996 846
1997 826
1998 917
1999 977
2000 1079
2001 1128
2002 1229
2003 1472
2004 1593
2005 1779
2006 1899
2007 2050
2008 2292
2009 2576
2010 2779
2011 3141
2012 3475
2013 3758
2014 3863
2015 3976
2016 4037
2017 4091
2018 4181
2019 4384
2020 4456
2021 4392
2022 4286
2023 3955
2024 1237

Text availability

Article attribute

Article type

Publication date

Search Results

72,133 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased risk of malignancy"
Page 1
Modifiable risk factors for colon cancer.
Giovannucci E. Giovannucci E. Gastroenterol Clin North Am. 2002 Dec;31(4):925-43. doi: 10.1016/s0889-8553(02)00057-2. Gastroenterol Clin North Am. 2002. PMID: 12489270 Review.
Red meat, processed meats, and perhaps refined carbohydrates contribute to risk. Recent evidence indicate that chronic hyperinsulinemia may increase risk of colon cancer. ...Of note is that hyperinsulinemia increases free IGF-1 exposure [25]. Hi …
Red meat, processed meats, and perhaps refined carbohydrates contribute to risk. Recent evidence indicate that chronic hyperinsulinem …
An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH, Hsu G, Siden EG, Thorlund K, Mills EJ. Park JJH, et al. CA Cancer J Clin. 2020 Mar;70(2):125-137. doi: 10.3322/caac.21600. Epub 2020 Feb 7. CA Cancer J Clin. 2020. PMID: 32031692 Free PMC article. Review.
A master protocol refers to a single, overarching design developed to evaluate multiple hypotheses with the general goal of improving the efficiency of trial evaluation. One type of master protocol is the basket trial, in which a targeted therapy is evaluated for mu …
A master protocol refers to a single, overarching design developed to evaluate multiple hypotheses with the general goal of improving the ef …
Avoidable flaws in observational analyses: an application to statins and cancer.
Dickerman BA, García-Albéniz X, Logan RW, Denaxas S, Hernán MA. Dickerman BA, et al. Nat Med. 2019 Oct;25(10):1601-1606. doi: 10.1038/s41591-019-0597-x. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591592 Free PMC article.
The increasing availability of large healthcare databases is fueling an intense debate on whether real-world data should play a role in the assessment of the benefit-risk of medical treatments. In many observational studies, for example, statin users were fou …
The increasing availability of large healthcare databases is fueling an intense debate on whether real-world data should play a role …
Post renal-transplant malignancy surveillance.
Manickavasagar R, Thuraisingham R. Manickavasagar R, et al. Clin Med (Lond). 2020 Mar;20(2):142-145. doi: 10.7861/clinmed.2019-0423. Clin Med (Lond). 2020. PMID: 32188647 Free PMC article. Review.
It is well recognised that kidney transplant recipients have an increased risk of cancers compared with the age and gender matched general population. ...This article reviews the epidemiology and risk factors for the development of malignancy in …
It is well recognised that kidney transplant recipients have an increased risk of cancers compared with the age and gen …
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE, Pooley N, Marjenberg Z, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, Hammond ER. Clarke AE, et al. Semin Arthritis Rheum. 2021 Dec;51(6):1230-1241. doi: 10.1016/j.semarthrit.2021.09.009. Epub 2021 Sep 30. Semin Arthritis Rheum. 2021. PMID: 34710720 Free article. Review.
The risk of 24 site-specific malignancies (62%) was increased in SLE patients. ...The risk of four malignancies (breast, uterine, melanoma, prostate) was decreased, whereas risk of 11 other malignancies did not …
The risk of 24 site-specific malignancies (62%) was increased in SLE patients. ...The risk of four …
Assessment of the risk of antiangiogenic agents before and after surgery.
Bailey CE, Parikh AA. Bailey CE, et al. Cancer Treat Rev. 2018 Jul;68:38-46. doi: 10.1016/j.ctrv.2018.05.002. Epub 2018 May 8. Cancer Treat Rev. 2018. PMID: 29793113 Review.
Because angiogenesis is an important step in the wound healing process, agents targeting the angiogenesis pathway may interfere with wound healing, thus increasing the risk of surgical wound complications, such as dehiscence, surgical site bleeding, and wound …
Because angiogenesis is an important step in the wound healing process, agents targeting the angiogenesis pathway may interfere with wound h …
Is P2Y12 inhibitor therapy associated with an increased risk of cancer?
Kaufmann CC, Lyon AR, Wojta J, Huber K. Kaufmann CC, et al. Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):100-104. doi: 10.1093/ehjcvp/pvz003. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 30657876 Review.
Antiplatelet therapy is a mainstay of cardiovascular therapy and is well established in clinical routine. Recently, the potential risk of solid cancers with P2Y12 inhibitor therapy has been an issue of growing interest. ...The higher risk of can …
Antiplatelet therapy is a mainstay of cardiovascular therapy and is well established in clinical routine. Recently, the potential …
Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice.
Stute P, Marsden J, Salih N, Cagnacci A. Stute P, et al. Maturitas. 2023 Aug;174:8-13. doi: 10.1016/j.maturitas.2023.04.271. Epub 2023 May 11. Maturitas. 2023. PMID: 37209498 Free article. Review.
Menopausal hormone treatment (MHT) is recommended for the management of menopause symptoms. The Women's Health Initiative (WHI) placebo-controlled randomised study examined the effects of continuous combined or estrogen-only MHT on the risk of non-communicabl …
Menopausal hormone treatment (MHT) is recommended for the management of menopause symptoms. The Women's Health Initiative (WHI) placebo-cont …
Male breast cancer.
Gómez-Raposo C, Zambrana Tévar F, Sereno Moyano M, López Gómez M, Casado E. Gómez-Raposo C, et al. Cancer Treat Rev. 2010 Oct;36(6):451-7. doi: 10.1016/j.ctrv.2010.02.002. Epub 2010 Mar 2. Cancer Treat Rev. 2010. PMID: 20193984 Review.
Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has increased over the past 25 years. The rarity of this entity precludes prospective randomized clinical trials. ...Familial cases usually have BRCA2 rather than BRCA1 mu …
Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has increased over the past 25 years. The rar …
Cancer issues.
Marsden J, Sturdee D. Marsden J, et al. Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):87-107. doi: 10.1016/j.bpobgyn.2008.10.005. Epub 2008 Nov 25. Best Pract Res Clin Obstet Gynaecol. 2009. PMID: 19036643
Unopposed oestrogen increases the risk of endometrial hyperplasia and carcinoma significantly, and this is dose and duration dependent. ...The use of combined oral contraception in premenopausal women also reduces the risk of endometrial cancer …
Unopposed oestrogen increases the risk of endometrial hyperplasia and carcinoma significantly, and this is dose and dur …
72,133 results
You have reached the last available page of results. Please see the User Guide for more information.